comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 23:02:26 - browse：846

Dr. Laurie Glimcher, CEO of Dana Farber Cancer Institute, opens both arms while talking — coverage from STAT — Laurie Glimcher, CEO of Dana Farber Cancer Institute, is the architect of the biggest shakeup in Boston health care in decades. David L. Ryan/Globe Staff

Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks.

The younger Glimcher took that advice to heart. In the late 1990s at her Harvard immunology lab, Glimcher and her postdoctoral student began a series of experiments that colleagues deemed “crazy.” But after a year of trial and error, the lab had a eureka moment when it found that white blood cells could be reprogrammed, a seminal discovery that led to new ways to treat cancer.

“Most scientists do good work, but they don’t transform a scientific question,” said Glimcher. “I always felt the only way to do that is to think big and go after something that’s going to be really important.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

WSS

STAT letters to the editor on burnt

Use wet bulb globe temperature, not heat index, to protect workers

Teach medical students about patients with intellectual disabilities

SCOTUS to consider access to abortion pill mifepristone

After sickle

In diabetes hearing, Sanders takes on a new foe: food makers

entertainment

comprehensive

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Pregnancy discrimination could be enabled by AI

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What causes an itch? Researchers may have solved the mystery

In age of alternative facts, a scholarly course on calling out crap

Patients' immediate access to test results puts radiologists in a bind

The cancer drug shortage isn’t new — and neither are the solutions

Study: People of West African ancestry at greater risk of cardiac amyloidosis

23andMe had bad news about my health. I wish a person had delivered it

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

focus

Software glitch causes Tandem insulin pump to shutdown, FDA warns

FDA needs staff influx to meet gene therapy needs, Marks says

Study: AI not yet building 'n

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Patients' immediate access to test results puts radiologists in a bind

Wikipedia

hotspot

hotspot

focus